Zydus
-
Zydus Wellness stock split: Why shares fall up to 80% today on some platforms?
Market | Sep 18, 2025, 01:28 PM ISTIn five, three and two years, the scrip has yielded a positive return of 36.76, 58.64 and 61.65 per cent, respectively. In one year, the scrip has gained 21.37 per cent, as against a 0.16 per cent correction in the benchmark index.
-
Zydus Life Chairman Pankaj R Patel named on RBI Central Board
Business | Jun 14, 2022, 02:24 PM ISTPankaj Patel was also the President of the Federation of Indian Chamber of Commerce & Industry (FICCI) (2016-17). He is also the Executive Chairman, Vice President and Trustee of the Gujarat Cancer Society and Chairman of the Gujarat Cancer and Research Institute.
-
Zydus Lifesciences Q4 profit declines 41% to Rs 397 cr
Market | May 20, 2022, 08:57 PM ISTThe company had posted a consolidated net profit of Rs 679 crore in the same quarter of previous fiscal year, Zydus Lifesciences said in a regulatory filing.
-
Zydus Cadila gets FDA's approval to market generic cancer drug in US
World | Nov 20, 2021, 03:54 PM ISTThe company has received final approval from the US Food and Drug Administration (USFDA) to Decitabine for Injection in the strength of 50 mg/vial single-dose vial, Zydus Cadila said in a statement.
-
Zydus Cadila gets USFDA nod for diabetes medication
Business | Sep 06, 2021, 01:24 PM ISTThe NDA received tentative approval upon completion of the first review cycle on September 2, 2021, Zydus Cadila stated.
-
Hope to start supply of ZyCoV-D vaccine by mid to end Sept: Zydus Group MD
India | Aug 21, 2021, 07:13 PM ISTThe company's indigenously developed needle-free three-dose COVID-19 vaccine ZyCoV-D was granted emergency use authorisation (EUA) by the drug regulator on Friday, making it the first vaccine to be administered to beneficiaries in the age group of 12-18 years in the country.
-
'ZyCoV-D' vaccine 66% efficient against Covid Delta variant: Zydus Group MD
India | Aug 23, 2021, 03:10 PM ISTZydus Group MD Dr. Sharvil Patel has claimed that 'ZyCoV-D' vaccine holds about 66% efficacy against the Delta variant of COVID-19.
-
Zydus Cadila's ZyCoV-D Covid vaccine gets approval for emergency use in India
News | Aug 21, 2021, 08:20 AM ISTThe Drugs Controller General of India (DCGI) on Friday gave approval for emergency-use authorization of Zydus Cadila's ZyCoV-D vaccine, the Union Ministry of Science and Technology said. The world’s first and India’s indigenously developed DNA-based vaccine for COVID-19 will be administered in humans including children and adults 12 years and above, the ministry said.
-
Zydus Cadila's Covid vaccine ZyCoV-D gets approval for Emergency Use Authorisation
News | Aug 20, 2021, 09:05 PM ISTThe Drugs Controller General of India (DCGI) on Friday gave approval for emergency-use authorization of Zydus Cadila's ZyCoV-D vaccine, the Union Ministry of Science and Technology said. The world’s first and India’s indigenously developed DNA-based vaccine for COVID-19 will be administered in humans including children and adults 12 years and above, the ministry said.